Phase III Study of Brexpiprazole in Adult Patients with Schizophrenia Published in American Journal of Psychiatry

anon79999497 April 23, 2015, 4:10am 2

1 Like

FDA Approves Otsuka and Lundbeck’s REXULTI (Brexpiprazole)

Topic		Replies	Views
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia News	0	860	February 16, 2015
Efficacy and safety of brexpiprazole (OPC-34712) as maintenance treatment in adults with schizophrenia: a randomised, double-blind, placebo-controlled study News	9	901	August 29, 2016
Brexpiprazole Displays Efficacy in Patients With Severe Psychotic Symptoms News	5	471	October 29, 2018
Brexpiprazole Maintenance Improves Psychosocial, Occupational Function in Schizophrenia News	4	648	October 23, 2016
Aripiprazole Lauroxil Shows Promise in Late-Stage Schizophrenia Trial News	8	1101	June 24, 2014